Concepedia

Sarah V. Gerhart

SV

Statistics

Publications

5

Citations

591

H-Index

5

Active since

2009

Affiliations

GlaxoSmithKline (United States)(Current)

Epizyme (United States)

Lehigh University

Sarah V. Gerhart is an author at GlaxoSmithKline (United States) specializing in life sciences, cell signaling, and molecular biology.

Publications per year

2009–2021

5

Publications

5

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 347 citations · Full text

, , +7

Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing

Sarah V. Gerhart, Wendy A. Kellner, Christine Thompson et al. · Scientific Reports · 2018 · 208 citations · Full text

, , +13

The Cx43-like Connexin Protein Cx40.8 Is Differentially Localized during Fin Ontogeny and Fin Regeneration

Sarah V. Gerhart, Diane M. Eble, R. Michael Burger et al. · PLoS ONE · 2012 · 15 citations · Full text

, , +16

Cx40.8, a Cx43‐like protein, forms gap junction channels inefficiently and may require Cx43 for its association at the plasma membrane

Sarah V. Gerhart, Rebecca Jefferis, M. Kathryn Iovine · FEBS Letters · 2009 · 11 citations · Full text

, , +11

A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation Profiling

Francesca Zappacosta, Craig D. Wagner, Anthony Della Pietra et al. · Molecular & Cellular Proteomics · 2021 · 10 citations · Full text

, , +17

1–5 of 5